Israel Active

Unilabs, one of Europe’s largest diagnostics companies, is to implement the AI-based cancer diagnostic software from Israel’s Ibex Medical Analytics (see previously). The initial rollout will begin in Sweden and then continue to 16 more European countries.

Israel’s MeMed (see previously) has received Europe’s CE mark for its Covid-19 Severity disease management solution. The 15-min test measures proteins from serum samples and applies machine learning to identify patients likely to suffer a severe form of coronavirus infection.

Israel’s Redhill has completed its Phase 2 / 3 clinical trials of its opaganib treatment on 475 coronavirus patients in Israel, Europe and Brazil. In a few weeks it will declare the results. Opaganib works on the patient rather than the virus, preventing the body from allowing the virus to enter the host cells.

Israel’s Oramed will shortly commence clinical trials of its Oravax vaccine - the world’s first oral Covid-19 vaccine (see previously). Phase 1/2 trials will take place at Tel Aviv’s Sourasky (Ichilov) Medical Center with Phase 3 in countries desperate for a vaccine.

Israel’s MediWound (see previously) successfully completed Phase 3 clinical trials of its NexoBrid treatment on children with severe thermal burns. The study evaluated 145 pediatric patients, from newborn to eighteen years of age, across 36 burn centers worldwide.

Solabia-Algatech Nutrition based at Kibbutz Ketura has launched BioGlena from whole Euglena gracilis algae grown on the Kibbutz. BioGlena contains over 55% β-glucan polysaccharides, touted as nature's immune-modulator, helping to prime and support natural immunity.

This article describes the latest progress of Israel’s Immunai (see previously) which is mapping the immune system to help develop new life-saving treatments. It acquired US-based Dropprint Genomics and has launched into development of cancer and autoimmune disease therapies.

Israel’s Betalin Therapeutics (see previously) is to receive capital from the European Innovation Council (EIC) fund. The funding will advance human trials of its biological pancreas that can produce insulin in the body independently, thus making injections unnecessary.

Alabama Regional Medical Services (ARMS) has selected the Remote Patient Monitoring (RPM) system from Israel’s DarioHealth (see previously) to improve the management of ARMS’s hypertension patients, including large numbers of underserved and uninsured patients.

The latest tool to be adopted by Israel against the coronavirus pandemic, rapid home virus-testing kits, is being made available to purchase in Israeli pharmacies as part of a pilot program.